Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Large Growth in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a large increase in short interest in October. As of October 15th, there was short interest totalling 9,900 shares, an increase of 50.0% from the September 30th total of 6,600 shares. Based on an average trading volume of 5,200 shares, the short-interest ratio is presently 1.9 days.

Fidelity Disruptive Medicine ETF Trading Up 0.6 %

Shares of FMED opened at $25.92 on Tuesday. Fidelity Disruptive Medicine ETF has a 12-month low of $19.88 and a 12-month high of $26.68. The company has a market cap of $54.43 million, a PE ratio of 35.73 and a beta of 0.94. The stock has a 50-day moving average price of $25.98 and a 200-day moving average price of $24.86.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

An institutional investor recently raised its position in Fidelity Disruptive Medicine ETF stock. Wealth Enhancement Advisory Services LLC grew its stake in shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 6.3% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 496,857 shares of the company’s stock after buying an additional 29,339 shares during the quarter. Wealth Enhancement Advisory Services LLC owned 23.44% of Fidelity Disruptive Medicine ETF worth $12,680,000 at the end of the most recent quarter.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.